METROPOLITAN LIFE INSURANCE CO/NY - CORCEPT THERAPEUTICS INC ownership

CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 246 filers reported holding CORCEPT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.1%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of CORCEPT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$126,117
+22.4%
4,6290.0%0.01%
+40.0%
Q2 2023$102,995
-3.1%
4,629
-5.7%
0.01%0.0%
Q1 2023$106,329
-2.8%
4,909
-8.9%
0.01%0.0%
Q4 2022$109,390
-20.8%
5,3860.0%0.01%
-28.6%
Q3 2022$138,097
+7.8%
5,3860.0%0.01%
+16.7%
Q2 2022$128,079
+5.6%
5,3860.0%0.01%
+50.0%
Q1 2022$121,293
-76.4%
5,386
-79.3%
0.00%
-42.9%
Q4 2021$514,127
+0.6%
25,9660.0%0.01%0.0%
Q3 2021$511,011
-18.0%
25,966
-8.3%
0.01%
-22.2%
Q2 2021$623,172
-1.2%
28,326
+6.8%
0.01%0.0%
Q1 2021$630,982
-12.4%
26,523
-3.6%
0.01%
-18.2%
Q4 2020$719,897
+36.0%
27,519
-9.5%
0.01%
+22.2%
Q3 2020$529,478
+3.5%
30,4210.0%0.01%0.0%
Q2 2020$511,681
+41.5%
30,4210.0%0.01%
+12.5%
Q1 2020$361,706
+0.2%
30,421
+1.9%
0.01%
+33.3%
Q4 2019$361,125
-17.5%
29,845
-3.7%
0.01%
-14.3%
Q3 2019$437,860
+26.8%
30,9770.0%0.01%
+16.7%
Q2 2019$345,394
-5.0%
30,9770.0%0.01%
-14.3%
Q1 2019$363,670
-12.1%
30,9770.0%0.01%
-12.5%
Q4 2018$413,853
-4.7%
30,9770.0%0.01%0.0%
Q3 2018$434,298
-99.9%
30,9770.0%0.01%0.0%
Q2 2018$486,958,000
-2.5%
30,977
+2.0%
0.01%
+14.3%
Q1 2018$499,587,000
+92587.8%
30,370
+1.7%
0.01%0.0%
Q4 2017$539,000
-55.7%
29,856
-52.6%
0.01%
-12.5%
Q3 2017$1,216,000
+63.7%
62,9970.0%0.01%
+60.0%
Q2 2017$743,000
+20.4%
62,997
+11.9%
0.01%
+25.0%
Q1 2017$617,000
+59.4%
56,303
+5.6%
0.00%
+33.3%
Q4 2016$387,000
+4.0%
53,311
-6.9%
0.00%0.0%
Q3 2016$372,000
+19.2%
57,244
+0.1%
0.00%
+50.0%
Q2 2016$312,000
+36.8%
57,179
+17.2%
0.00%0.0%
Q1 2016$228,000
+12.9%
48,807
+20.2%
0.00%0.0%
Q4 2015$202,000
+32.0%
40,6040.0%0.00%
+100.0%
Q3 2015$153,000
-34.1%
40,604
+5.1%
0.00%
-50.0%
Q2 2015$232,000
-5.7%
38,629
-12.2%
0.00%0.0%
Q1 2015$246,000
+19.4%
44,002
-6.7%
0.00%
+100.0%
Q1 2014$206,00047,1790.00%
Other shareholders
CORCEPT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
INGALLS & SNYDER LLC 8,370,017$181,2959.31%
Novo Holdings A/S 3,377,768$73,162,4554.83%
Parallel Advisors, LLC 3,724,573$80,674,2512.72%
TANAKA CAPITAL MANAGEMENT INC 35,539$7702.24%
Shay Capital LLC 350,000$7,581,0001.49%
Shay Capital LLC 350,000$7,581,0001.49%
S&T BANK/PA 350,924$7,6011.37%
Birchview Capital, LP 50,000$1,0830.85%
Clearview Wealth Advisors LLC 34,275$742,3970.75%
Granite Investment Partners, LLC 795,076$17,221,3460.72%
View complete list of CORCEPT THERAPEUTICS INC shareholders